Serum interleukin-6 as a neuroinflammatory biomarker across the spectrum of neurological disorders: a large-scale retrospective cohort study of 6,465 individuals - Takeaways - MDSpire

Serum interleukin-6 as a neuroinflammatory biomarker across the spectrum of neurological disorders: a large-scale retrospective cohort study of 6,465 individuals

  • By

  • Lingjun Zhao

  • Zhaoming Tang

  • Chengliang Zhu

  • May 13, 2026

Share

  • 1

    Serum IL-6 levels significantly vary across 10 neurological disorders, with the highest levels in traumatic brain injury, metabolic/toxic encephalopathy, and hemorrhagic stroke.

  • 2

    Independent predictors of serum IL-6 levels include disease category, age with a U-shaped association, and male sex, all showing statistical significance.

  • 3

    IL-6 demonstrates strong diagnostic performance for distinguishing acute brain injuries from healthy individuals, with AUC values exceeding 0.9 for several conditions.

  • 4

    The diagnostic utility of IL-6 is limited for differentiating between various neurological diseases, particularly between traumatic brain injury and others.

  • 5

    A proposed clinical interpretation framework for serum IL-6 testing requires further validation in multi-center studies to confirm its utility in emergency settings.

Original Source(s)

Related Content